• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Emergent BioSolutions

Emergent BioSolutions

  1. Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414

    Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414

  2. Yen Declines After Sudden Jump, ECB in Focus

    Yen Declines After Sudden Jump, ECB in Focus

  3. CURRENCIES: Yen Declines After Sudden Jump, ECB In Focus

    CURRENCIES: Yen Declines After Sudden Jump, ECB In Focus

  4. Yen declines after sudden jump, ECB in focus

    Yen declines after sudden jump, ECB in focus

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.